Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of Fluconazole 150 mg vs Diflucan in Healthy Volunteers
NCT03929861Phase 1Completed
- Sponsor
- Bayer
- Start
- Jul 2012
- Primary completion
- Sep 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of fluconazole in candidiasis (2 arms), sponsored by Bayer. Primary endpoints: Maximum Plasma Concentration and Area Under the Curve from time 0 to last measurable concentration. Started Jul 2012; status: completed.
02
Drugs
fluconazole
03
Conditions
candidiasis
Beyond the preview
Go deeper on NCT03929861.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03929861.